Filtered By:
Cancer: Skin Cancer

This page shows you your search results in order of relevance. This is page number 18.

Order by Relevance | Date

Total 55943 results found since Jan 2013.

Laser surgery for skin cancer
Ray Jalian, M.D., recently led a study that showed lasers to be a promising alternative therapy to remove based cell carcinoma. Dr. Jalian joins "Sound Medicine" to comment on the new procedure, the pros and cons of the Mohs procedure, and what the future looks like for treating basal cell carcinoma with lasers.....
Source: Sound Medicine - April 6, 2014 Category: Global & Universal Authors: Sound Medicine Source Type: news

Change in a child's naevus prompts referral to a dermatology service.
DISCUSSION: Change in a lesion, though a common trigger for referral, is less likely to indicate malignancy in children compared with adults and, as a sole criterion, does not necessitate specialist referral. Teledermoscopy clinics offer high quality macroscopic and dermatoscopic images and can assist in providing reassurance, where appropriate. PMID: 24892129 [PubMed - in process]
Source: Primary Care - June 8, 2014 Category: Primary Care Authors: Cheng H, Oakley A, Rademaker M Tags: J Prim Health Care Source Type: research

A Case of Lung Cancer Originating from Cavitary Mycobacterium xenopi Infection.
Abstract Coexistence of Mycobacterium xenopi with lung cancer has been reported. However, lung cancer originating within a pre-existing cavity caused by M. xenopi has not. A 55-y-old woman with a history of smoking presented with complaints of chronic dry cough, night sweats, and weight loss for several months. Computed tomography (CT) scanning revealed a 3.5-cm irregular thick-walled cavity in the right lung apex. Cultures obtained from a CT-guided biopsy grew M. xenopi. The patient received standard treatment, and her clinical symptoms improved, and the radiographic lesion stabilized. However, 2 y later, a repea...
Source: Respiratory Care - October 21, 2014 Category: Respiratory Medicine Authors: Doshi VK, Kulkarni SR, Kham NM, Kapitan KS Tags: Respir Care Source Type: research

Palliative treatment of thiamine-related encephalopathy (Wernicke's encephalopathy) in cancer: A case series and review of the literature.
This report adds to the list of cancer types in which TRE/Wernicke's encephalopathy has been reported. It supports the use of higher doses of thiamine than are typically recommended in North America. Improvement following treatment allowed patients to engage with family and treatment teams prior to death. PMID: 25339378 [PubMed - as supplied by publisher]
Source: Palliative and Supportive Care - October 23, 2014 Category: Palliative Care Authors: Isenberg-Grzeda E, Hsu AJ, Hatzoglou V, Nelso C, Breitbart W Tags: Palliat Support Care Source Type: research

Anti‐tumor effect of Japanese herbal medicine Ninjinto in mouse melanoma: Efficacy of preventive treatment
ConclusionNinjinto showed anti‐tumor efficacy against B16F1 melanoma in vitro and in vivo. The significant enhancement of innate immunity and CD4 T‐cell immune response, and the improved immune tolerance suggest induction of effective anti‐tumor immune responses.
Source: Traditional and Kampo Medicine - December 1, 2014 Category: Complementary Medicine Authors: Noriaki Nakai, Tsunao Kishida, Norito Katoh Tags: ORIGINAL ARTICLE Source Type: research

Diffuse Interstitial Pulmonary Infiltrates in Malignant Melanoma.
We report a case of a 25-y-old man who presented to our department with diffuse interstitial pulmonary infiltrates and slightly enlarged mediastinal lymph nodes as determined by computed tomography. He had a history of malignant melanoma with 18 months of interferon alpha-2 therapy. Histological analysis of a transbronchial biopsy revealed sarcoidosis-like reactions. PMID: 25587168 [PubMed - as supplied by publisher]
Source: Respiratory Care - January 13, 2015 Category: Respiratory Medicine Authors: Bräunlich J, Seyfarth HJ, Frille A, Wirtz H Tags: Respir Care Source Type: research

Tailoring the Treatment of Melanoma: Implications for Personalized Medicine.
Authors: Duan L, Mukherjee EM, Narayan D Abstract Oncology has been revolutionized by the ability to selectively inhibit the growth of cancerous cells while ostensibly avoiding the disruption of proteins and pathways necessary for normal cellular function. This paradigm has triggered an explosion of targeted therapies for cancer, creating a burgeoning billion-dollar industry of small molecules and monoclonal antibodies [1]. Largely due to these new treatments, spending on cancer pharmaceuticals has surpassed $100 billion worldwide [2]. In particular, the treatment of melanoma, a deadly and fast-spreading form of sk...
Source: The Yale Journal of Biology and Medicine - November 27, 2015 Category: Universities & Medical Training Tags: Yale J Biol Med Source Type: research

Skin Cancer.
Abstract Skin cancer accounts for most malignancies across the globe. They are primarily divided into melanoma and nonmelanoma skin malignancies. Nonmelanoma skin cancer includes basal cell carcinoma and squamous cell carcinoma. Fair skin and chronic ultraviolet B exposure are the most important risk factors. Primary prevention is achieved by avoiding sun exposure and tanning beds. PMID: 26612377 [PubMed - in process]
Source: Primary Care - November 30, 2015 Category: Primary Care Authors: Linares MA, Zakaria A, Nizran P Tags: Prim Care Source Type: research

Melanoma: understanding relevant molecular pathways as well as available and emerging therapies.
Abstract Since 2011, 6 therapies, including cell signaling kinase inhibitors and immune checkpoint targeting antibodies, have been approved by the FDA for the treatment of melanoma. Due to advancements in research and a greater understanding of the role of the immune system in cancer as well as the molecular biology of melanoma tumors, novel therapies are emerging to combat and effectively manage melanoma tumors. Advances in research are resulting in prolonging rates of survival of patients with metastatic melanoma. Research is ongoing to gain deeper insight to discover (1) which patients are most likely to respon...
Source: The American Journal of Managed Care - September 1, 2015 Category: Health Management Authors: McKibbin T Tags: Am J Manag Care Source Type: research

When cancer cannot be cured: A qualitative study on relationship changes in couples facing advanced melanoma.
Abstract OBJECTIVE: The aim of this qualitative study was to gain a deeper understanding about couples' relationship changes over time (the first six months) after one partner is diagnosed with an incurable advanced melanoma (stage III or IV). METHOD: In semistructured interviews, eight patients and their partners were asked separately about potential changes in their relationship since diagnosis. The same questions were asked again six months later, but focusing on relationship changes over the preceding six months. Some 32 audiotaped interviews were analyzed applying qualitative content analysis. RESUL...
Source: Palliative and Supportive Care - March 15, 2016 Category: Palliative Care Authors: Drabe N, Jenewein J, Weidt S, Engeli L, Meier C, Büchi S, Schad K, Schönbucher V, Canella C, Nuñez DG Tags: Palliat Support Care Source Type: research

Inclusion of populations at risk of advanced melanoma in an opportunistic targeted screening project involving general practitioners.
CONCLUSION: This study demonstrated inequalities in the inclusion of patients in a melanoma screening. Patients at risk of advanced cancer were screened less often. Further studies should focus on GPs ability to identify and screen these patients. KEY POINTS Advanced melanoma is more frequently diagnosed in men, older patients and socioeconomically disadvantaged populations, which leads to survival inequalities. • Despite the involvement of general practitioners, the implementation of targeted melanoma screening did not avoid inclusion inequalities. • Men, older patients, patients suffering from chronic diseases, a...
Source: Primary Care - July 27, 2016 Category: Primary Care Authors: Rat C, Quereux G, Grimault C, Fernandez J, Poiraud M, Gaultier A, Chaslerie A, Pivette J, Khammari A, Dreno B, Nguyen JM Tags: Scand J Prim Health Care Source Type: research

An expanded portfolio of survival metrics for assessing anticancer agents.
CONCLUSIONS: This analysis suggests that any 1 metric may not completely characterize the expected survival benefit of all patients. The cost-value analysis tool may be applied to trial data and may be useful in helping to make treatment decisions, regardless of the agent's effectiveness. A combined metric will be needed, as well as further research that includes more mature data, other tumor types, and emerging treatments. PMID: 28141932 [PubMed - in process]
Source: The American Journal of Managed Care - December 31, 2016 Category: Health Management Authors: Karweit J, Kotapati S, Wagner S, Shaw JW, Wolfe SW, Abernethy AP Tags: Am J Manag Care Source Type: research

Optimal three-dimensional reconstruction for lung cancer tissues.
Abstract The existing three-dimensional (3D) x-ray reconstruction methods for lung cancer tissue reconstruct the investigated objects based on a series of two-dimensional (2D) image sections and a chosen 3D reconstruction algorithm. However, because these procedures apply the same segmentation method for all 2D image sections, they may not achieve the optimal segmentation for each section. As a result, the reconstructed 3D images have limited spatial resolution. Furthermore, the existing 3D reconstruction method is time-consuming and results in a limited time resolution. This research presents an innovation of 3D ...
Source: Technology and Health Care - May 26, 2017 Category: Medical Devices Authors: Huang X, Yue S, Wang C, Wang H Tags: Technol Health Care Source Type: research

Future Medicine's Oncology Management series of journals to be fully Open Access from 2018
(Future Science Group) Future Medicine is pleased to announce that, from January 2018, the eight journals within its Oncology Management Series -- Breast Cancer Management, CNS Oncology, Colorectal Cancer, Hepatic Oncology, International Journal of Endocrine Oncology, International Journal of Hematologic Oncology, Lung Cancer Management and Melanoma Management, will be following a fully open access model.
Source: EurekAlert! - Medicine and Health - January 26, 2018 Category: International Medicine & Public Health Source Type: news